Literature DB >> 15801859

Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors.

Fabien Fontaine1, Manuel Pastor, Ismael Zamora, Ferran Sanz.   

Abstract

The aim of this work is to present the anchor-GRIND methodology. Anchor-GRIND efficiently combines a priori chemical and biological knowledge about the studied compounds with alignment-independent molecular descriptors derived from molecular interaction fields. Such descriptors are particularly useful for series of ligands sharing a common scaffold but with very diverse substituents. The method uses a specific position of the molecular structure (the "anchor point") to compare the spatial distribution of the molecular interaction fields of the substituents. The descriptors produced are more detailed and specific than the original GRIND while still avoiding the bias introduced by the alignment. Three data sets have been studied to demonstrate the usefulness of the anchor-GRIND methodology for 3D-QSAR modeling. The two first data sets respectively include congeneric series of the hepatitis C virus NS3 protease and of the acetylcholinesterase inhibitors. The third data set discriminates between factor Xa inhibitors of high and low affinity. In all the series presented, the models obtained with the anchor-GRIND are statistically sound and easy to interpret.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15801859     DOI: 10.1021/jm049113+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  CHEMICAL COMPOUND CLASSIFICATION WITH AUTOMATICALLY MINED STRUCTURE PATTERNS.

Authors:  A M Smalter; J Huan; G H Lushington
Journal:  Proc Asia Pac Bioinform Conf       Date:  2008

2.  Representation of molecular structure using quantum topology with inductive logic programming in structure-activity relationships.

Authors:  Bård Buttingsrud; Einar Ryeng; Ross D King; Bjørn K Alsberg
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

3.  Boosted feature selectors: a case study on prediction P-gp inhibitors and substrates.

Authors:  Gonzalo Cerruela García; Nicolás García-Pedrajas
Journal:  J Comput Aided Mol Des       Date:  2018-10-26       Impact factor: 3.686

4.  ChemTreeMap: an interactive map of biochemical similarity in molecular datasets.

Authors:  Jing Lu; Heather A Carlson
Journal:  Bioinformatics       Date:  2016-08-11       Impact factor: 6.937

5.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.

Authors:  Fabio Broccatelli; Emanuele Carosati; Annalisa Neri; Maria Frosini; Laura Goracci; Tudor I Oprea; Gabriele Cruciani
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

6.  Estimation of the applicability domain of kernel-based machine learning models for virtual screening.

Authors:  Nikolas Fechner; Andreas Jahn; Georg Hinselmann; Andreas Zell
Journal:  J Cheminform       Date:  2010-03-11       Impact factor: 5.514

7.  Classifying and scoring of molecules with the NGN: new datasets, significance tests, and generalization.

Authors:  Eddie Y T Ma; Christopher J F Cameron; Stefan C Kremer
Journal:  BMC Bioinformatics       Date:  2010-10-26       Impact factor: 3.169

8.  Open Babel: An open chemical toolbox.

Authors:  Noel M O'Boyle; Michael Banck; Craig A James; Chris Morley; Tim Vandermeersch; Geoffrey R Hutchison
Journal:  J Cheminform       Date:  2011-10-07       Impact factor: 5.514

9.  Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Front Pharmacol       Date:  2015-05-13       Impact factor: 5.810

10.  2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein.

Authors:  Ishrat Jabeen; Penpun Wetwitayaklung; Peter Chiba; Manuel Pastor; Gerhard F Ecker
Journal:  J Comput Aided Mol Des       Date:  2013-02-12       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.